世界の口内乾燥症（口渇症）治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Xerostomia (Dry Mouth Disease) Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z6093 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、口内乾燥症（口渇症）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（人工唾液、唾液刺激剤、唾液代替物、薬物、唾液ペン、その他）、用途別市場規模（小売薬局、病院薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・口内乾燥症（口渇症）治療薬の市場動向 ・企業の競争状況、市場シェア ・口内乾燥症（口渇症）治療薬の種類別市場規模（人工唾液、唾液刺激剤、唾液代替物、薬物、唾液ペン、その他） ・口内乾燥症（口渇症）治療薬の用途別市場規模（小売薬局、病院薬局、オンライン薬局） ・口内乾燥症（口渇症）治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・口内乾燥症（口渇症）治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・口内乾燥症（口渇症）治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・口内乾燥症（口渇症）治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・口内乾燥症（口渇症）治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Acacia Pharma、Church & Dwight、GlaxoSmithKline、Hikma Pharmaceuticals、Lupin、OraCoat、Parnell Pharmaceuticals、Pendopharm、Pfizer、Sun Pharmaceutical Industries、Synedgen） ・結論

Xerostomia is a subjective feeling, caused by different reasons, many of the systemic many diseases are complications, some are the result of inevitable development. The side effect of the medicine is also one of the important factors that cause dry mouth. Xerostomia is a condition caused by a lack of saliva in the mouth. The amount of saliva in the mouth depends on the balance between production and consumption. If the amount of saliva produced is less than the amount consumed, there is a negative balance, indicating dry mouth.

Market Analysis and Insights: Global Xerostomia (Dry Mouth Disease) Therapeutics Market
The global Xerostomia (Dry Mouth Disease) Therapeutics market size is projected to reach US$ 657.9 million by 2026, from US$ 556.9 million in 2019, at a CAGR of 2.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Xerostomia (Dry Mouth Disease) Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Xerostomia (Dry Mouth Disease) Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Xerostomia (Dry Mouth Disease) Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Xerostomia (Dry Mouth Disease) Therapeutics market.

Global Xerostomia (Dry Mouth Disease) Therapeutics Scope and Market Size
Xerostomia (Dry Mouth Disease) Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Xerostomia (Dry Mouth Disease) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Artificial Saliva
Salivary Stimulants
Saliva Substitutes
Drugs
Salivary Pens
Others

Segment by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Acacia Pharma
Church & Dwight
GlaxoSmithKline
Hikma Pharmaceuticals
Lupin
OraCoat
Parnell Pharmaceuticals
Pendopharm
Pfizer

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Xerostomia (Dry Mouth Disease) Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Artificial Saliva
1.2.3 Salivary Stimulants
1.2.4 Saliva Substitutes
1.2.5 Drugs
1.2.6 Salivary Pens
1.2.7 Others
1.3 Market by Application
1.3.1 Global Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Xerostomia (Dry Mouth Disease) Therapeutics Market Perspective (2016-2027)
2.2 Xerostomia (Dry Mouth Disease) Therapeutics Growth Trends by Regions
2.2.1 Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Xerostomia (Dry Mouth Disease) Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Xerostomia (Dry Mouth Disease) Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Xerostomia (Dry Mouth Disease) Therapeutics Industry Dynamic
2.3.1 Xerostomia (Dry Mouth Disease) Therapeutics Market Trends
2.3.2 Xerostomia (Dry Mouth Disease) Therapeutics Market Drivers
2.3.3 Xerostomia (Dry Mouth Disease) Therapeutics Market Challenges
2.3.4 Xerostomia (Dry Mouth Disease) Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Xerostomia (Dry Mouth Disease) Therapeutics Players by Revenue
3.1.1 Global Top Xerostomia (Dry Mouth Disease) Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Xerostomia (Dry Mouth Disease) Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Xerostomia (Dry Mouth Disease) Therapeutics Revenue
3.4 Global Xerostomia (Dry Mouth Disease) Therapeutics Market Concentration Ratio
3.4.1 Global Xerostomia (Dry Mouth Disease) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Xerostomia (Dry Mouth Disease) Therapeutics Revenue in 2020
3.5 Xerostomia (Dry Mouth Disease) Therapeutics Key Players Head office and Area Served
3.6 Key Players Xerostomia (Dry Mouth Disease) Therapeutics Product Solution and Service
3.7 Date of Enter into Xerostomia (Dry Mouth Disease) Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Xerostomia (Dry Mouth Disease) Therapeutics Breakdown Data by Type
4.1 Global Xerostomia (Dry Mouth Disease) Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Xerostomia (Dry Mouth Disease) Therapeutics Forecasted Market Size by Type (2022-2027)

5 Xerostomia (Dry Mouth Disease) Therapeutics Breakdown Data by Application
5.1 Global Xerostomia (Dry Mouth Disease) Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Xerostomia (Dry Mouth Disease) Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size (2016-2027)
6.2 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type
6.2.1 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2027)
6.3 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application
6.3.1 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2027)
6.4 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country
6.4.1 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size (2016-2027)
7.2 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type
7.2.1 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2027)
7.3 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application
7.3.1 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2027)
7.4 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country
7.4.1 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type
8.2.1 Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application
8.3.1 Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Region
8.4.1 Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size (2016-2027)
9.2 Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type
9.2.1 Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application
9.3.1 Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country
9.4.1 Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type
10.2.1 Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application
10.3.1 Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country
10.4.1 Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Acacia Pharma
11.1.1 Acacia Pharma Company Details
11.1.2 Acacia Pharma Business Overview
11.1.3 Acacia Pharma Xerostomia (Dry Mouth Disease) Therapeutics Introduction
11.1.4 Acacia Pharma Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
11.1.5 Acacia Pharma Recent Development
11.2 Church & Dwight
11.2.1 Church & Dwight Company Details
11.2.2 Church & Dwight Business Overview
11.2.3 Church & Dwight Xerostomia (Dry Mouth Disease) Therapeutics Introduction
11.2.4 Church & Dwight Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
11.2.5 Church & Dwight Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Xerostomia (Dry Mouth Disease) Therapeutics Introduction
11.3.4 GlaxoSmithKline Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Hikma Pharmaceuticals
11.4.1 Hikma Pharmaceuticals Company Details
11.4.2 Hikma Pharmaceuticals Business Overview
11.4.3 Hikma Pharmaceuticals Xerostomia (Dry Mouth Disease) Therapeutics Introduction
11.4.4 Hikma Pharmaceuticals Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
11.4.5 Hikma Pharmaceuticals Recent Development
11.5 Lupin
11.5.1 Lupin Company Details
11.5.2 Lupin Business Overview
11.5.3 Lupin Xerostomia (Dry Mouth Disease) Therapeutics Introduction
11.5.4 Lupin Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
11.5.5 Lupin Recent Development
11.6 OraCoat
11.6.1 OraCoat Company Details
11.6.2 OraCoat Business Overview
11.6.3 OraCoat Xerostomia (Dry Mouth Disease) Therapeutics Introduction
11.6.4 OraCoat Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
11.6.5 OraCoat Recent Development
11.7 Parnell Pharmaceuticals
11.7.1 Parnell Pharmaceuticals Company Details
11.7.2 Parnell Pharmaceuticals Business Overview
11.7.3 Parnell Pharmaceuticals Xerostomia (Dry Mouth Disease) Therapeutics Introduction
11.7.4 Parnell Pharmaceuticals Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
11.7.5 Parnell Pharmaceuticals Recent Development
11.8 Pendopharm
11.8.1 Pendopharm Company Details
11.8.2 Pendopharm Business Overview
11.8.3 Pendopharm Xerostomia (Dry Mouth Disease) Therapeutics Introduction
11.8.4 Pendopharm Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
11.8.5 Pendopharm Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Xerostomia (Dry Mouth Disease) Therapeutics Introduction
11.9.4 Pfizer Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Sun Pharmaceutical Industries
11.10.1 Sun Pharmaceutical Industries Company Details
11.10.2 Sun Pharmaceutical Industries Business Overview
11.10.3 Sun Pharmaceutical Industries Xerostomia (Dry Mouth Disease) Therapeutics Introduction
11.10.4 Sun Pharmaceutical Industries Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
11.10.5 Sun Pharmaceutical Industries Recent Development
11.11 Synedgen
11.11.1 Synedgen Company Details
11.11.2 Synedgen Business Overview
11.11.3 Synedgen Xerostomia (Dry Mouth Disease) Therapeutics Introduction
11.11.4 Synedgen Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
11.11.5 Synedgen Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Artificial Saliva
Table 3. Key Players of Salivary Stimulants
Table 4. Key Players of Saliva Substitutes
Table 5. Key Players of Drugs
Table 6. Key Players of Salivary Pens
Table 7. Key Players of Others
Table 8. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Regions (2016-2021)
Table 12. Global Xerostomia (Dry Mouth Disease) Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Regions (2022-2027)
Table 14. Xerostomia (Dry Mouth Disease) Therapeutics Market Trends
Table 15. Xerostomia (Dry Mouth Disease) Therapeutics Market Drivers
Table 16. Xerostomia (Dry Mouth Disease) Therapeutics Market Challenges
Table 17. Xerostomia (Dry Mouth Disease) Therapeutics Market Restraints
Table 18. Global Xerostomia (Dry Mouth Disease) Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Players (2016-2021)
Table 20. Global Top Xerostomia (Dry Mouth Disease) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Xerostomia (Dry Mouth Disease) Therapeutics as of 2020)
Table 21. Ranking of Global Top Xerostomia (Dry Mouth Disease) Therapeutics Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Xerostomia (Dry Mouth Disease) Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Xerostomia (Dry Mouth Disease) Therapeutics Product Solution and Service
Table 25. Date of Enter into Xerostomia (Dry Mouth Disease) Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Xerostomia (Dry Mouth Disease) Therapeutics Revenue Market Share by Type (2016-2021)
Table 29. Global Xerostomia (Dry Mouth Disease) Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Xerostomia (Dry Mouth Disease) Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Xerostomia (Dry Mouth Disease) Therapeutics Revenue Market Share by Application (2016-2021)
Table 33. Global Xerostomia (Dry Mouth Disease) Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Xerostomia (Dry Mouth Disease) Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 65. Acacia Pharma Company Details
Table 66. Acacia Pharma Business Overview
Table 67. Acacia Pharma Xerostomia (Dry Mouth Disease) Therapeutics Product
Table 68. Acacia Pharma Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021) & (US$ Million)
Table 69. Acacia Pharma Recent Development
Table 70. Church & Dwight Company Details
Table 71. Church & Dwight Business Overview
Table 72. Church & Dwight Xerostomia (Dry Mouth Disease) Therapeutics Product
Table 73. Church & Dwight Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021) & (US$ Million)
Table 74. Church & Dwight Recent Development
Table 75. GlaxoSmithKline Company Details
Table 76. GlaxoSmithKline Business Overview
Table 77. GlaxoSmithKline Xerostomia (Dry Mouth Disease) Therapeutics Product
Table 78. GlaxoSmithKline Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021) & (US$ Million)
Table 79. GlaxoSmithKline Recent Development
Table 80. Hikma Pharmaceuticals Company Details
Table 81. Hikma Pharmaceuticals Business Overview
Table 82. Hikma Pharmaceuticals Xerostomia (Dry Mouth Disease) Therapeutics Product
Table 83. Hikma Pharmaceuticals Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021) & (US$ Million)
Table 84. Hikma Pharmaceuticals Recent Development
Table 85. Lupin Company Details
Table 86. Lupin Business Overview
Table 87. Lupin Xerostomia (Dry Mouth Disease) Therapeutics Product
Table 88. Lupin Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021) & (US$ Million)
Table 89. Lupin Recent Development
Table 90. OraCoat Company Details
Table 91. OraCoat Business Overview
Table 92. OraCoat Xerostomia (Dry Mouth Disease) Therapeutics Product
Table 93. OraCoat Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021) & (US$ Million)
Table 94. OraCoat Recent Development
Table 95. Parnell Pharmaceuticals Company Details
Table 96. Parnell Pharmaceuticals Business Overview
Table 97. Parnell Pharmaceuticals Xerostomia (Dry Mouth Disease) Therapeutics Product
Table 98. Parnell Pharmaceuticals Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Parnell Pharmaceuticals Recent Development
Table 100. Pendopharm Company Details
Table 101. Pendopharm Business Overview
Table 102. Pendopharm Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021) & (US$ Million)
Table 103. Pendopharm Recent Development
Table 104. Pfizer Company Details
Table 105. Pfizer Business Overview
Table 106. Pfizer Xerostomia (Dry Mouth Disease) Therapeutics Product
Table 107. Pfizer Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021) & (US$ Million)
Table 108. Pfizer Recent Development
Table 109. Sun Pharmaceutical Industries Company Details
Table 110. Sun Pharmaceutical Industries Business Overview
Table 111. Sun Pharmaceutical Industries Xerostomia (Dry Mouth Disease) Therapeutics Product
Table 112. Sun Pharmaceutical Industries Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021) & (US$ Million)
Table 113. Sun Pharmaceutical Industries Recent Development
Table 114. Synedgen Company Details
Table 115. Synedgen Business Overview
Table 116. Synedgen Xerostomia (Dry Mouth Disease) Therapeutics Product
Table 117. Synedgen Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021) & (US$ Million)
Table 118. Synedgen Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Artificial Saliva Features
Figure 3. Salivary Stimulants Features
Figure 4. Saliva Substitutes Features
Figure 5. Drugs Features
Figure 6. Salivary Pens Features
Figure 7. Others Features
Figure 8. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Application: 2020 VS 2027
Figure 9. Retail Pharmacies Case Studies
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Xerostomia (Dry Mouth Disease) Therapeutics Report Years Considered
Figure 13. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Regions: 2020 VS 2027
Figure 16. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Regions (2022-2027)
Figure 17. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Players in 2020
Figure 18. Global Top Xerostomia (Dry Mouth Disease) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Xerostomia (Dry Mouth Disease) Therapeutics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Xerostomia (Dry Mouth Disease) Therapeutics Revenue in 2020
Figure 20. Global Xerostomia (Dry Mouth Disease) Therapeutics Revenue Market Share by Type (2016-2021)
Figure 21. Global Xerostomia (Dry Mouth Disease) Therapeutics Revenue Market Share by Type (2022-2027)
Figure 22. North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Type (2016-2027)
Figure 24. North America Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Application (2016-2027)
Figure 25. North America Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Country (2016-2027)
Figure 26. United States Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Type (2016-2027)
Figure 30. Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Application (2016-2027)
Figure 31. Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Country (2016-2027)
Figure 32. Germany Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Region (2016-2027)
Figure 42. China Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Type (2016-2027)
Figure 50. Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Application (2016-2027)
Figure 51. Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Country (2016-2027)
Figure 52. Mexico Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Country (2016-2027)
Figure 58. Turkey Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Acacia Pharma Revenue Growth Rate in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
Figure 62. Church & Dwight Revenue Growth Rate in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
Figure 64. Hikma Pharmaceuticals Revenue Growth Rate in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
Figure 65. Lupin Revenue Growth Rate in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
Figure 66. OraCoat Revenue Growth Rate in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
Figure 67. Parnell Pharmaceuticals Revenue Growth Rate in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
Figure 68. Pendopharm Revenue Growth Rate in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
Figure 69. Pfizer Revenue Growth Rate in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
Figure 70. Sun Pharmaceutical Industries Revenue Growth Rate in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
Figure 71. Synedgen Revenue Growth Rate in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---